Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Org Lett ; 21(14): 5407-5412, 2019 07 19.
Artigo em Inglês | MEDLINE | ID: mdl-31184172

RESUMO

The structures of five linear lipopeptides, thaxteramides A1, A2, B1, B2, and C isolated from the myxobacterium Jahnella thaxteri, were elucidated. They have a C-terminal common tetrapeptidic Tyr-Gly-ß-Ala-Tyr core but differ in the stereochemistry of the tyrosine units, methylations, the remaining amino acids, and the N-terminal polyketide. In silico analysis of the genome sequence complemented with feeding experiments revealed two distinct hybrid PKS/NRPS gene clusters. Three semisynthesized cyclic analogues were found to inhibit the growth of Gram-positive bacteria.


Assuntos
Lipopeptídeos/biossíntese , Myxococcales/metabolismo , Sequência de Aminoácidos , Simulação por Computador , Lipopeptídeos/química
2.
Chembiochem ; 15(15): 2221-4, 2014 Oct 13.
Artigo em Inglês | MEDLINE | ID: mdl-25147087

RESUMO

Natural product peptide-based proteasome inhibitors show great potential as anticancer drugs. Here we have cloned the biosynthetic gene cluster of a potent proteasome inhibitor-glidobactin from Burkholderia DSM7029-and successfully detected glidobactins/luminmycins in E. coli Nissle. We have also improved the yield of glidobactin A tenfold by promoter change in a heterologous host. In addition, two new biosynthetic intermediates were identified by comparative MS/MS fragmentation analysis. Identification of acyclic luminmycin E implies substrate specificity of the TE domain for cyclization. The establishment of a heterologous expression system for syrbactins provided the basis for the generation of new syrbactins as proteasome inhibitors by molecular engineering, but the TE domain's specificity cannot be ignored.


Assuntos
Produtos Biológicos/metabolismo , Burkholderia/genética , Escherichia coli/genética , Escherichia coli/metabolismo , Família Multigênica/genética , Oligopeptídeos/biossíntese , Produtos Biológicos/química , Conformação Molecular , Oligopeptídeos/química , Oligopeptídeos/genética , Peptídeos Cíclicos/biossíntese , Peptídeos Cíclicos/química , Peptídeos Cíclicos/genética , Estereoisomerismo
3.
Chembiochem ; 8(17): 2139-44, 2007 Nov 23.
Artigo em Inglês | MEDLINE | ID: mdl-17955482

RESUMO

Myxalamids are potent inhibitors of the eukaryotic electron transport chain produced by different myxobacteria. Here, we describe the identification of the myxalamid biosynthesis gene cluster from Myxococcus xanthus. Additionally, new myxalamids (5-13) have been obtained by mutasynthesis from bkd mutants of M. xanthus and Stigmatella aurantiaca. Moreover, as these bkd mutants are still able to produce myxalamid B (2), the origin of the isobutyryl-CoA (IB-CoA) starter unit required for its biosynthesis has been determined. In a M. xanthus bkd mutant, IB-CoA originates from valine, but in S. aurantiaca this starter unit is derived from alpha-oxidation of iso-odd fatty acids, thereby connecting primary and secondary metabolism.


Assuntos
Acil Coenzima A/metabolismo , Cromatografia Líquida de Alta Pressão , Estrutura Molecular , Família Multigênica , Mutação/genética , Myxococcus xanthus/enzimologia , Myxococcus xanthus/genética , Polienos/química , Polienos/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...